Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Effecty vs Pallas Health

By GLP-1 ScorecardUpdated

EffectyFactor scores not reassessed.
Site position #21

Higher score

Pallas HealthFactor scores not reassessed.
Site position #142

Lower score

Score comparison

Effecty has the higher recorded score — 83.7/100 to 69.3/100.

Effecty grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Separate compounded/branded offers; confirm discounts, billing and exit terms.

Before you choose

Before comparing the headline prices, the Effecty review and the Pallas Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Effecty vs Peptivo and Gala Health vs Pallas Health compare each of them with another graded program, and the list of alternatives to Effecty ranks the programs closest to Effecty on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Direct Meds review covers one graded close to these two, at 77.6/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEffecty +25
80
55
Dose & formulationEffecty +8
84
76
Clinical oversightEffecty +1
85
84
Labs & monitoringEffecty +32
84
52
FulfillmentEffecty +1
87
86
Contract termsEffecty +18
86
68
Effecty · top barPallas Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEffectyPallas Health
WeighScore83.7/10069.3/100
GradeBC
Site position#21#142
Semaglutide$170/month before code; advertised $95 first month. Supply unconfirmed.$139 first period, then $199 every four weeks (compounded; confirm selected quote)
Tirzepatide$235/month before code; advertised $160 first month. Supply unconfirmed.$179 first period, then $299 every four weeks (compounded; confirm selected quote)
CoverageNationwide shipping claimed; confirm treatment-specific eligibility.Confirm treatment and visit requirements for your state
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Effecty

Site position #21 · B

Factor scores not reassessed.

Strengths

  • Medication-specific billing terms
  • Dose-independent pricing advertised
  • Separate Wegovy offer published

What to consider

  • Selected total/supply unconfirmed
  • Prescription sales described as final
  • Assigned pharmacy and individual credentials unverified
Pallas Health

Site position #142 · C

Factor scores not reassessed.

Strengths

  • Publishes first-period and four-week renewal amounts
  • Explains when the charge is triggered and how to cancel future renewal
  • Terms link to a pharmacy partner directory

What to consider

  • Annual monthly equivalents do not establish the selected debit
  • Once prescribed, the current cycle ordinarily is not prorated or refunded
  • The six-month promise has separate eligibility and timing requirements

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard